Tag: Diabetes: Type II
Risk for T2DM Increased With Use of 5α-Reductase Inhibitors
Increased risk seen among men using dutasteride, finasteride for benign prostatic hyperplasia
Low-Carb Breakfast May Improve All-Day Glucose Control in T2DM
In addition, high-fat, low-carb breakfast tied to less hunger later in the day
Added Sugar Labeling Could Reduce CVD, Diabetes Cases
Labeling would result in gain in quality-adjusted life-years and health care and societal cost savings
Canagliflozin Seems Effective for Patients With T2DM, Kidney Disease
Reductions seen in risk for kidney failure, cardiovascular disease with canagliflozin versus placebo
Early T2DM Diagnosis Linked to Increased Cardiovascular Risk
Highest excess risk for mortality, CV mortality, heart failure, CHD seen for T2DM patients diagnosed before 40
Topical Corticosteroids Associated With Higher Risk for Type 2 Diabetes
Dose-response relationship observed in large European cohort
Liquid Meal Replacements Cut Cardiometabolic Risk Factors
Effects observed in overweight/obese patients with T2DM; certainty of evidence low to moderate
Frailty May Up Fracture Risk in Patients With Type 2 Diabetes
Diabetes patients have higher frailty scores, which are tied to risk for incident fragility fractures
Statins Tied to Insulin Resistance, Higher Serum Fasting Insulin
Ever use of statins associated with 38 percent increased risk for incident type 2 diabetes
Patients With Diabetes at Increased Risk for Sleep Apnea
In addition to known predictors of apnea, diabetes-related foot disease, insulin treatment up risk
